| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2005 | CN1569218A Bone peptide for injection and its preparation method |
| 01/26/2005 | CN1569217A Manufacturing method of metallothionin contained tablet for removing lead |
| 01/26/2005 | CN1569007A Amino acid liquor and its preparation method |
| 01/26/2005 | CN1568906A Stainless steel cardiovascular bracket with pharmaceutical coating on surface and preparation method thereof |
| 01/26/2005 | CN1186637C Use of chemotaxin-oid factor-1 in preparation of antibody with the action of curing inflammatory damage of organs |
| 01/26/2005 | CN1186448C Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use |
| 01/26/2005 | CN1186353C 17 peptide organic compound and its application |
| 01/26/2005 | CN1186352C HAb18G(/CD147) peptide agonist and its prepn and use |
| 01/26/2005 | CN1186097C Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 01/26/2005 | CN1186096C Hemostatics powder and preparation thereof |
| 01/26/2005 | CN1186095C Usage of clostridium toxin or its compound in the preparation process of Therapeutic agent snoring noises suppressing agent |
| 01/26/2005 | CN1186094C Piracetam medicine composition with function of promoting thinking and memory and its preparation |
| 01/26/2005 | CN1186092C Anticancer Chinese medicine powder preparation and its preparation method |
| 01/26/2005 | CN1186087C Chinese medical preparation for preventing and treating cardiovascular, cerebrovascular diseases and its preparation method |
| 01/26/2005 | CN1186012C Continuously releasing ionic conjuncts |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
| 01/25/2005 | US6846921 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846914 Ligand for use in the treatment of tumors, injuries, thrombosis, atherosclerosis and inflammatory diseases |
| 01/25/2005 | US6846913 Crude extract from Viscum album coloratum, and proteins and lectins isolated therefrom |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846883 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 01/25/2005 | US6846844 (3R)-5-((2-hydroxy-4-methylphenyl)amino)-3-methyl-5-oxo-pentan oic acid, or 3,5-dichloro derivative or salts thereof; deliver active agents to selected biological systems in increased or improved bioavailability |
| 01/25/2005 | US6846841 Anti-angiogenic compositions and methods of use |
| 01/25/2005 | US6846831 Method of treating the syndrome of lipodystrophy |
| 01/25/2005 | US6846806 Peptide inhibitors of Hepatitis C virus NS3 protein |
| 01/25/2005 | US6846805 Oligopeptides or polypeptides used to inhibit transmembrane proteases such as aspartyl secretases, administered for prophylaxis of neurodegenerative diseases; Alzheimer's disease |
| 01/25/2005 | US6846803 Hybrid polynucleotide |
| 01/25/2005 | US6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 01/25/2005 | US6846801 Systemic administration of a therapeutic preparation |
| 01/25/2005 | US6846800 Method for treating a patient having metabolic syndrome |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846673 Recovering preferential cell for use in the propagation of human protein; obtain cells, incubate with modulators, monitor cell propagation, transform with vector contain protein and regulatory sequences, recover protein |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 01/25/2005 | US6846663 Regulation of target protein activity through modifier proteins |
| 01/25/2005 | US6846662 Vertebrate telomerase genes and proteins and uses thereof |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846647 Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods |
| 01/25/2005 | US6846644 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 01/25/2005 | US6846640 Identifying modulators of polypeptide aggregation; for treating alzheimer's, down's syndrome, huntington's, parkinson's, prion, amyotrophic lateral sclerosis, lewy bodies and/or diabetic diseases |
| 01/25/2005 | US6846623 LGMD gene coding for a calcium dependent protease |
| 01/25/2005 | US6846494 Aftertreatment surgery; mixture of protein, carbohydrates, fats, arginine, ascorbic acid, tocophenol and flavonoids |
| 01/25/2005 | US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant |
| 01/25/2005 | US6846486 Vaccine; therapy, prevention asthma; mixture of antihistamine antibody and interferons; antiallergens |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | US6846484 Fusion toxin comprising the toxin domain of diphtheria toxin and a urokinase-type plasminogen activator domain; killing tumor cells, especially glioblastoma cells |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/25/2005 | CA2089853C Polyethylene glycol-hirudine conjugates, process for their preparation, and their use in thrombosis therapy |
| 01/20/2005 | WO2005005652A2 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants |
| 01/20/2005 | WO2005005632A2 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME |
| 01/20/2005 | WO2005005631A1 Hla-a24 binding cancer antigen peptide derived from ribin |
| 01/20/2005 | WO2005005630A2 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 01/20/2005 | WO2005005627A2 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | WO2005005626A1 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 01/20/2005 | WO2005005477A2 Stabilised insulin compositions |
| 01/20/2005 | WO2005005476A1 Modified epidermal growth factors |
| 01/20/2005 | WO2005005471A2 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 01/20/2005 | WO2005005463A1 Antifungal cyclic lipopeptides |
| 01/20/2005 | WO2005005462A2 Blys antagonists and uses thereof |
| 01/20/2005 | WO2005005436A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004905A1 Use of calpain for identifying compounds that modulate pain |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | WO2005004903A1 Method for treating oncological diseases |
| 01/20/2005 | WO2005004902A1 Recombinant human serum albumin preparation accommodated in plastic container |
| 01/20/2005 | WO2005004901A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 01/20/2005 | WO2005004900A1 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 01/20/2005 | WO2005004899A2 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 01/20/2005 | WO2005004898A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 01/20/2005 | WO2005004897A1 Water-soluble shps as novel alkylating agents |
| 01/20/2005 | WO2005004896A1 Nop receptor antagonists for the treatment of parkinson’s disease |
| 01/20/2005 | WO2005004895A2 Compositions and methods for enhanced mucosal delivery of growth hormone |
| 01/20/2005 | WO2005004894A2 Methods for increasing cell and tissue viability |
| 01/20/2005 | WO2005004893A2 Inhibition of stress-induced ligand-dependent egfr activation |
| 01/20/2005 | WO2005004886A1 Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| 01/20/2005 | WO2005004848A1 The solid dispersion of tacrolimus |
| 01/20/2005 | WO2005004838A1 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 01/20/2005 | WO2005004804A2 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 01/20/2005 | WO2005004795A2 Compositions and methods for targeted drug delivery |
| 01/20/2005 | WO2005004792A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 01/20/2005 | WO2005004789A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 01/20/2005 | WO2005004639A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 01/20/2005 | WO2004106519A3 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004105780A3 Compositions comprising gastrin compounds and their use in diabetes |
| 01/20/2005 | WO2004101826A3 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi |
| 01/20/2005 | WO2004101611A3 Peptides that bind to the erythropoietin receptor |
| 01/20/2005 | WO2004099248A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) |
| 01/20/2005 | WO2004099235A3 Bacteriocins and novel bacterial strains |